Jadelle® : Progesterone-only implant contraception

Jadelle® is a long-acting reversible contraception (LARC) initially approved for use in the US in 1996.  Jadelle®is now approved in more than 44 countries and used by more than 3 million women worldwide.

By the end of the course you will be able to:

• Advise women and men requesting contraception and enable them to make informed choices about managing their fertility.
• Appropriately consult with and assess women who wish to use the Jadelle® implant.
• Understand the composition and pharmacokinetics of the Jadelle® implant and potential drug interactions.
• Explain the indications and contraindications, medical eligibility criteria, advantages and disadvantages, side effects and complications of Jadelle® implant use.
• Understand the mode of action and contraceptive efficacy of implants.
• Manage side effects of Jadelle® including bleeding problems.
• Describe the management of an impalpable implant.

Certification

Once you have completed this short course and quiz, please click 'submit' where you will be taken to the results page. From here you can print your certificate for 2 hours of Continuing Professional Development points.

Acknowledgements

This content was created by Dr Orna McGinn, MRCGP (UK) DRCOG DFFP FRCNZGP in February 2017.

The material is presented by the Goodfellow Unit (GFU), an accredited continuing medical education/ continuing professional development (CME/CPD) provider for the Royal New Zealand College of General Practitioners and functions under a tripartite agreement between the Goodfellow Foundation, the College and the University of Auckland. The Unit is located within the Department of General Practice and Primary Health Care, and within the School of Population Health.